Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0CR9I
|
||||
Former ID |
DIB011106
|
||||
Drug Name |
CX-5011
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [1] | ||
Company |
Cylene Pharmaceuticals Inc
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C20H11N4NaO2
|
||||
Canonical SMILES |
c1ncc2c(n1)c(nc1c2ccc(c1)C(=O)O)Nc1cc(ccc1)C#C
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Casein kinase II, alpha chain | Target Info | Inhibitor | [1] | |
KEGG Pathway | Ribosome biogenesis in eukaryotes | ||||
NF-kappa B signaling pathway | |||||
Wnt signaling pathway | |||||
Adherens junction | |||||
Tight junction | |||||
Measles | |||||
Herpes simplex infection | |||||
Epstein-Barr virus infection | |||||
NetPath Pathway | FSH Signaling Pathway | ||||
Pathway Interaction Database | BCR signaling pathway | ||||
Atypical NF-kappaB pathway | |||||
DNA-PK pathway in nonhomologous end joining | |||||
Presenilin action in Notch and Wnt signaling | |||||
Role of Calcineurin-dependent NFAT signaling in lymphocytes | |||||
E-cadherin signaling in the nascent adherens junction | |||||
Lissencephaly gene (LIS1) in neuronal migration and development | |||||
PDGFR-alpha signaling pathway | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
Alpha-synuclein signaling | |||||
Reactome | Condensation of Prometaphase Chromosomes | ||||
WikiPathways | Mitotic Prometaphase | ||||
BDNF signaling pathway | |||||
TNF alpha Signaling Pathway | |||||
L1CAM interactions | |||||
References | |||||
REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1549). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.